深入分析不同基于生理的药代动力学建模工具的选择模式:第一部分-使用开源代码软件的应用程序和基本原理

IF 1.7 4区 医学 Q3 PHARMACOLOGY & PHARMACY
Arham Jamaal Rajput, Hamza Khaled Abdelmajed Aldibani, Amin Rostami-Hodjegan
{"title":"深入分析不同基于生理的药代动力学建模工具的选择模式:第一部分-使用开源代码软件的应用程序和基本原理","authors":"Arham Jamaal Rajput,&nbsp;Hamza Khaled Abdelmajed Aldibani,&nbsp;Amin Rostami-Hodjegan","doi":"10.1002/bdd.2357","DOIUrl":null,"url":null,"abstract":"<p>PBPK applications published in the literature support a greater adoption of non-open source-code (NOSC) software as opposed to open source-code (OSC) alternatives. However, a significant number of PBPK modelers are still using OSC software, understanding the rationale for the use of this modality is important and may help those embarking on PBPK modeling. No previous analysis of PBPK modeling trends has included the rationale of the modeler. An in-depth analysis of PBPK applications of OSC software is warranted to determine the true impact of OSC software on the rise of PBPK. Publications focusing on PBPK modeling applications, which used OSC software, were identified by systematically searching the scientific literature for original articles. A total of 171 articles were extracted from the narrowed subset. The rise in the use of OSC software for PBPK applications was greater than the general discipline of pharmacokinetics (9 vs. 4), but less than the overall growth of the PBPK area (9 vs. 43). Our report demonstrates conclusively that the surge in PBPK usage is primarily attributable to the availability and implementations of NOSC software. Modelers preferred not to share the reasons for their selection of certain modeling software and no ‘explicit’ rationale was given to support the use of OSC analysed by this study. As the preference for NOSC versus OSC software tools in the PBPK area continues to be divided, initiatives to add the rationale in using one form over another to every future PBPK modeling report will be a welcomed and informative addition.</p>","PeriodicalId":8865,"journal":{"name":"Biopharmaceutics & Drug Disposition","volume":"44 3","pages":"274-285"},"PeriodicalIF":1.7000,"publicationDate":"2023-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/bdd.2357","citationCount":"2","resultStr":"{\"title\":\"In-depth analysis of patterns in selection of different physiologically based pharmacokinetic modeling tools: Part I – Applications and rationale behind the use of open source-code software\",\"authors\":\"Arham Jamaal Rajput,&nbsp;Hamza Khaled Abdelmajed Aldibani,&nbsp;Amin Rostami-Hodjegan\",\"doi\":\"10.1002/bdd.2357\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>PBPK applications published in the literature support a greater adoption of non-open source-code (NOSC) software as opposed to open source-code (OSC) alternatives. However, a significant number of PBPK modelers are still using OSC software, understanding the rationale for the use of this modality is important and may help those embarking on PBPK modeling. No previous analysis of PBPK modeling trends has included the rationale of the modeler. An in-depth analysis of PBPK applications of OSC software is warranted to determine the true impact of OSC software on the rise of PBPK. Publications focusing on PBPK modeling applications, which used OSC software, were identified by systematically searching the scientific literature for original articles. A total of 171 articles were extracted from the narrowed subset. The rise in the use of OSC software for PBPK applications was greater than the general discipline of pharmacokinetics (9 vs. 4), but less than the overall growth of the PBPK area (9 vs. 43). Our report demonstrates conclusively that the surge in PBPK usage is primarily attributable to the availability and implementations of NOSC software. Modelers preferred not to share the reasons for their selection of certain modeling software and no ‘explicit’ rationale was given to support the use of OSC analysed by this study. As the preference for NOSC versus OSC software tools in the PBPK area continues to be divided, initiatives to add the rationale in using one form over another to every future PBPK modeling report will be a welcomed and informative addition.</p>\",\"PeriodicalId\":8865,\"journal\":{\"name\":\"Biopharmaceutics & Drug Disposition\",\"volume\":\"44 3\",\"pages\":\"274-285\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2023-04-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/bdd.2357\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biopharmaceutics & Drug Disposition\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/bdd.2357\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biopharmaceutics & Drug Disposition","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/bdd.2357","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 2

摘要

文献中发布的PBPK应用程序支持更多地采用非开源代码(NOSC)软件,而不是开源代码(OSC)替代品。然而,相当数量的PBPK建模者仍在使用OSC软件,理解使用这种模式的基本原理很重要,可能有助于那些开始PBPK建模的人。以前对PBPK建模趋势的分析没有包括建模器的基本原理。为了确定OSC软件对PBPK兴起的真正影响,有必要对OSC软件的PBPK应用进行深入分析。通过系统地搜索科学文献中的原创文章,确定了使用OSC软件的PBPK建模应用程序的出版物。从缩小的子集中共提取了171篇文章。在PBPK应用中使用OSC软件的增加大于药代动力学的一般学科(9比4),但低于PBPK领域的总体增长(9比43)。我们的报告确凿地表明,PBPK使用量的激增主要归因于NOSC软件的可用性和实现。建模者不愿意分享他们选择某些建模软件的原因,也没有给出“明确的”理由来支持本研究分析的盐含量的使用。由于在PBPK领域对NOSC和OSC软件工具的偏好仍然存在分歧,在未来的每个PBPK建模报告中添加使用一种形式而不是另一种形式的基本原理的倡议将是一个受欢迎的和有益的补充。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

In-depth analysis of patterns in selection of different physiologically based pharmacokinetic modeling tools: Part I – Applications and rationale behind the use of open source-code software

In-depth analysis of patterns in selection of different physiologically based pharmacokinetic modeling tools: Part I – Applications and rationale behind the use of open source-code software

PBPK applications published in the literature support a greater adoption of non-open source-code (NOSC) software as opposed to open source-code (OSC) alternatives. However, a significant number of PBPK modelers are still using OSC software, understanding the rationale for the use of this modality is important and may help those embarking on PBPK modeling. No previous analysis of PBPK modeling trends has included the rationale of the modeler. An in-depth analysis of PBPK applications of OSC software is warranted to determine the true impact of OSC software on the rise of PBPK. Publications focusing on PBPK modeling applications, which used OSC software, were identified by systematically searching the scientific literature for original articles. A total of 171 articles were extracted from the narrowed subset. The rise in the use of OSC software for PBPK applications was greater than the general discipline of pharmacokinetics (9 vs. 4), but less than the overall growth of the PBPK area (9 vs. 43). Our report demonstrates conclusively that the surge in PBPK usage is primarily attributable to the availability and implementations of NOSC software. Modelers preferred not to share the reasons for their selection of certain modeling software and no ‘explicit’ rationale was given to support the use of OSC analysed by this study. As the preference for NOSC versus OSC software tools in the PBPK area continues to be divided, initiatives to add the rationale in using one form over another to every future PBPK modeling report will be a welcomed and informative addition.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.60
自引率
0.00%
发文量
35
审稿时长
6-12 weeks
期刊介绍: Biopharmaceutics & Drug Dispositionpublishes original review articles, short communications, and reports in biopharmaceutics, drug disposition, pharmacokinetics and pharmacodynamics, especially those that have a direct relation to the drug discovery/development and the therapeutic use of drugs. These includes: - animal and human pharmacological studies that focus on therapeutic response. pharmacodynamics, and toxicity related to plasma and tissue concentrations of drugs and their metabolites, - in vitro and in vivo drug absorption, distribution, metabolism, transport, and excretion studies that facilitate investigations related to the use of drugs in man - studies on membrane transport and enzymes, including their regulation and the impact of pharmacogenomics on drug absorption and disposition, - simulation and modeling in drug discovery and development - theoretical treatises - includes themed issues and reviews and exclude manuscripts on - bioavailability studies reporting only on simple PK parameters such as Cmax, tmax and t1/2 without mechanistic interpretation - analytical methods
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信